Drug-Drug Interaction Study of ABP-671 in Gout Patients

Clinical trial NCT07367971 · RECRUITING

Trial details

NCT number: NCT07367971
Sponsor: Atom Therapeutics Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gout Chronic Gout DDI (Drug-Drug Interaction)

Start date: 2026-01-23
Primary completion: 2026-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.